On November 20, 2024 Rakovina Therapeutics Inc. (TSX-V: RKV) ("Rakovina" or the "Company"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response targeting technologies, reported an upcoming poster presentation highlighting preliminary results of its Deep Docking and generative Artificial Intelligence (AI) drug development program at the Neuro-Oncology Annual Meeting in Houston, Texas, on November 22, 2024 (Press release, Rakovina Therapeutics, NOV 20, 2024, View Source;utm_medium=rss&utm_campaign=rakovina-therapeutics-announces-upcoming-poster-presentation-at-the-29th-annual-society-for-neuro-oncology-meeting-in-houston-texas [SID1234648524]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The poster will be available to conference attendees as virtual e-posters on the virtual meeting platform on November 22, 2024.
Poster Details:
Title: Utilizing Artificial Intelligence for the Discovery of Novel PARP1-Selective Inhibitors for Use Against Brain Tumors
Presentation Date: November 22, 2024
Session: 7:30pm CST
Abstract Number: DDDR-15
About the Annual Society for Neuro-Oncology (SNO) Annual Meeting
The SNO Annual Meeting is the premier global event in neuro-oncology, bringing together over 2,600 researchers, clinicians, and scientists from more than 40 countries to advance the field of neuro-oncology. This influential conference will feature leading experts in oncology, providing a platform for the latest research, treatments, and innovations. The 2024 meeting will take place at the George R. Brown Convention Center in Houston, Texas, from November 21-24. For more information, visit: View Source